Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2000
08/17/2000WO2000047741A1 Glycosylated leptin compositions and related methods
08/17/2000WO2000047736A1 Polypeptide variants with raised heparin-binding capacity
08/17/2000WO2000047731A1 Protein having dna helicase activity, polynucleotide encoding the protein, antisense polynucleotide against the polynucleotide and antibody recognizing the protein
08/17/2000WO2000047715A2 Dwf4 polynucleotides, polypeptides and uses thereof
08/17/2000WO2000047622A2 Peptides with anti-angiogenic activity
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047223A2 Viral vaccine
08/17/2000WO2000034317A3 Method for reducing immunogenicity of proteins
08/17/2000WO2000030590A3 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
08/17/2000WO2000024769A3 Process for recovering heterologous polypeptide from bacterial refractile particles
08/17/2000WO2000024766A3 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
08/17/2000WO2000018912A3 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
08/17/2000WO2000015784A3 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
08/17/2000WO2000015665A3 A method of producing a functional immunoglobulin superfamily protein
08/17/2000WO2000014230A9 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
08/17/2000DE19906096A1 Protein mit einem Heparin-bindenden Epitop Protein having a heparin-binding epitope
08/17/2000CA2362603A1 Dwf4 polynucleotides, polypeptides and uses thereof
08/17/2000CA2362524A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
08/17/2000CA2361293A1 33 human secreted proteins
08/16/2000EP1028315A2 Target specific screens and their use for discovering small organic molecular pharmacophores
08/16/2000EP1027896A1 Broadly reactive opsonic antibodies that react with common staphyloccoccal antigens
08/16/2000EP1027450A1 Method of dna shuffling
08/16/2000EP1027444A1 Reagents and methods useful for detecting diseases of the breast
08/16/2000EP1027441A2 Murine dna molecules encoding polypeptides having kinase functions
08/16/2000EP1027440A1 Inhibitor protein of the wnt signal pathway
08/16/2000EP1027438A2 Novel cytokine receptors
08/16/2000EP1027437A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
08/16/2000EP1027431A2 April- a novel protein with growth effects
08/16/2000EP1027430A1 64 human secreted proteins
08/16/2000EP1027375A1 Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
08/16/2000EP1027066A1 Soluble mhc complexes and methods of use thereof
08/16/2000EP0759302B1 Remedy for rheumatoid arthritis
08/16/2000EP0753015B1 Monoclonal antibodies recognizing tie-receptor and their use
08/16/2000EP0668914B1 Crystallization of m-csf
08/16/2000CN1263598A Antibodies and SCFV immunotoxins specific to imported fire ants, and their application
08/16/2000CN1263560A Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in sample of normal cells
08/16/2000CN1263556A Anti-GPIIB/IIIA recombinant antibodies
08/16/2000CN1263555A Human TOLL-like receptor proteins, related reagents and methods
08/16/2000CN1263160A Electric production method of protein
08/16/2000CN1263158A Recombinant superoxide dismutase gene sequence and preparation method of its engineering bacterium and product
08/16/2000CN1263156A New neurotrophic hormone factor, its coding sequence, its preparation and application
08/16/2000CN1263155A New human protein and its coding sequence
08/16/2000CN1055500C DNA sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom
08/16/2000CN1055499C Regulatory nucleotde sequence of initiation of transcription
08/16/2000CA2296764A1 Growth hormone-regulated growth marker
08/15/2000US6103889 Nucleic acid molecules encoding single-chain antigen-binding proteins
08/15/2000US6103882 Producing a peptide ligand, amide or salt by subjecting fusion protein or peptide to cleavage of the peptide bond on the amino terminal side of a cysteine in the heterologous peptide
08/15/2000US6103880 Amino acid sequence of mitogenic peptide; angiogenic agents especially for brain structures; wound healing agents for skin; for bone regeneration especially osteoporosis
08/15/2000US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer
08/15/2000US6103869 Isolated polypeptide with a mutation at amino acid 464, 465, and/or 467 resulting in dominant negative inhibition of transforming growth factor-beta signaling; therapy and diagnosis of related diseases
08/15/2000US6103767 Physiologically active substances TKR1785's, process for the preparation thereof, and microbe
08/15/2000US6103693 Method for isolation of highly pure von willebrand factor
08/15/2000US6103512 Thermostable variants of neutral proteases of Bacillus stearothermophilus and Bacillus thermoproteolyticus
08/15/2000US6103507 Protein used to raise an immunological response against a bacteria; bactericides
08/15/2000US6103502 Ultrafiltration process for desalination and concentration of a peptide in a cell-free fermentation medium
08/15/2000US6103501 Recombinant protein which can be utilized as agonist or antagonist to its native cellular counterparts
08/15/2000US6103500 Production of tissue factor pathway inhibitor
08/15/2000US6103495 Direct expression of peptides into culture media
08/15/2000US6103491 Methods and compositions for identifying morphogen analogs
08/15/2000US6103489 Cell-free protein synthesis system with protein translocation and processing
08/15/2000US6103484 Method for immunodiagnosis of heartworm in mammals
08/15/2000US6103238 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines
08/15/2000US6103237 More stable to purification than wild type mature hk2 polypeptide.
08/15/2000US6103234 Antibody to an inflammatory cytokine, said inflammatory cytokine comprising a mature macrophage inflammatory protein -2 (mmip-2)
08/15/2000US6103229 Regulator gene from Ustilago maydis
08/15/2000CA2196431C Icam-4 materials and methods
08/15/2000CA2046601C Production and use of anthelmintic agents and protective immunogens
08/15/2000CA1341086C Thermally stable and ph stable subtilisin analogs and method for production thereof
08/15/2000CA1341083C Purified recombinant interleukin-2 and process for recovering and purifying same
08/10/2000WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
08/10/2000WO2000046390A1 T helper cell epitopes
08/10/2000WO2000046389A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000WO2000046375A2 Methods for producing polypeptides in fungal cells
08/10/2000WO2000046368A1 Transporter gene octn3
08/10/2000WO2000046350A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
08/10/2000WO2000046344A2 Non-stochastic generation of genetic vaccines and enzymes
08/10/2000WO2000046343A2 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation
08/10/2000WO2000046243A1 Process for preparing coagulants for water treatment
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046236A2 Novel rgs-containing molecules and uses thereof
08/10/2000WO2000046233A1 Pigment protein from coral tissue
08/10/2000WO2000045644A1 Process of bio-conversion of industrial or agricultural cellulose containing organic wastes
08/10/2000WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof
08/10/2000WO2000024937A3 Parallel methods for genomic analysis
08/10/2000WO2000024773A3 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
08/10/2000WO2000010599A8 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
08/10/2000CA2492661A1 Non-stochastic generation of genetic vaccines and enzymes
08/10/2000CA2362239A1 Novel rgs-containing molecules and uses thereof
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361658A1 T helper cell epitopes
08/10/2000CA2361038A1 Pigment protein from coral tissue
08/10/2000CA2360865A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000CA2360745A1 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation
08/10/2000CA2360670A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
08/09/2000WO2000052043A1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide
08/09/2000EP1026250A1 DNA-constructs of blood clotting factors and P-selectin
08/09/2000EP1026240A2 Generation and selection of recombinant varied binding proteins
08/09/2000EP1026239A2 A new method for tapping the immunological repertoire
08/09/2000EP1026238A2 Cloned glutamic acid decarboxylase
08/09/2000EP1026237A2 Tau/neurofilament protein kinases pk40 & pk36